首页> 外文期刊>The journal of pain: official journal of the American Pain Society >Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose
【24h】

Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose

机译:慢性阿片类药物治疗风险降低措施对阿片类药物过量的影响

获取原文
获取原文并翻译 | 示例
       

摘要

We assessed the effects of opioid dose and risk reduction initiatives on opioid overdose rates among patients on chronic opioid therapy (COT). Using an interrupted time series design, we compared trends in overdose rates. We compared patients on COT in settings that implemented a COT dose reduction initiative and then a COT risk stratification/monitoring initiative to similar patients on COT from control settings. From 2006 to 2014, 31,142 patients on COT (22,673 intervention, 8,469 control) experienced 311 fatal or nonfatal opioid overdoses. In primary analyses, changes in opioid overdose rates among patients on COT did not differ significantly between intervention and control settings with the implementation of either dose reduction or risk stratification/monitoring. In planned secondary analyses, overdose rates decreased significantly (17% per year) during the dose reduction initiative among patients on COT in intervention settings (relative annual change, 0.83; 95% confidence interval, 0.70-0.99), but not in control settings (0.98. 95% confidence interval, 0.70-1.39). We conclude that overdose rates among patients on COT were not decreased by risk stratification and monitoring initiatives. Results were inconsistent for COT dose reduction, with no significant difference between intervention and control settings (primary hypothesis test), but a significant decrease in overdose rates within the intervention setting during dose reduction (secondary hypothesis test).
机译:我们评估了阿片类药物剂量和风险降低措施对慢性阿片类药物治疗(COT)患者阿片类药物过量率的影响。使用中断的时间序列设计,我们比较过量率的趋势。我们将患者与患者的患者进行比较,以实现婴儿床剂量降低倡议,然后是对照环境中COT上同类患者的COT风险分层/监测倡议。从2006年到2014年,COT上31,142名患者(22,673介入,8,469次)经历了311次致命或非常规阿片类药物过量。在初级分析中,COT患者的阿片类药物过量率的变化在干预和控制环境之间没有显着差异,实施剂量减少或风险分层/监测。在计划的二级分析中,过量率在干预环境中的患者的剂量减少促进期间减少了显着(每年17%)(相对年度变化,0.83; 95%置信区间,0.70-0.99),但不在控制设置中( 0.98。95%置信区间,0.70-1.39)。我们得出结论,婴儿床患者的过量速率没有通过风险分层和监测举措减少。结果对婴儿床剂量降低不一致,干预和控制环境(原发性假设试验)之间无显着差异,但在剂量还原期间干预设定内过量速率的显着降低(二次假设试验)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号